A Study of Automated Myocardial Performance Index Before, During and After Fetal Surgeries using Samsung HERA W10

Overview

About this study

The purpose of this study is to evaluate the cardiac function in fetuses with specific conditions before, during, and after fetal interventions using an automated myocardial performance index.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Pregnant women, aged 18 years or older, with one of the following prenatal diagnoses:
- Monochorionic diamniotic twin pregnancies complicated with TTTS
- Fetuses with CDH, but no other structural or chromosomal abnormalities
- Fetuses with NTD, but no other structural or chromosomal abnormalities
- Fetuses with LUTO, but no other structural or chromosomal abnormalities
That provide written Informed Consent and is willing to comply with protocol requirements

Exclusion Criteria:

Presence of fetal cardiac anomalies, arrhythmias, associated morbid or lethal anomalies, chromosomal abnormalities.
Pregnancy complications that are known to impact fetal and neonatal outcomes (e.g., diabetes mellitus, hypertension, autoimmune disorders.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Rodrigo Ruano, M.D., Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Rodrigo Ruano, M.D., Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials